Tools & Calculators
Sector: Pharmaceuticals & Biotechnology
|Large Cap
Abbott India Ltd.
₹26,405
Invest in ABBOTINDIA with up to 3.33x margin.
Trade with MTF₹25990.00
₹26550.00
₹26000.00
₹37000.00
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 1,724.04 | 1,757.15 | 1,738.35 | 1,604.59 | 1,614.28 |
| Operating Expense | 1,260.57 | 1,254.98 | 1,292.76 | 1,176.05 | 1,178.19 |
| Operating Profit | 463.47 | 502.17 | 445.59 | 428.54 | 436.09 |
| Depreciation | 18.77 | 18.64 | 19.48 | 17.93 | 17.99 |
| Interest | 5.48 | 7.55 | 5.82 | 3.92 | 2.26 |
| Tax | 133.02 | 130.66 | 127.27 | 115.67 | 126.81 |
| Net Profit | 375.96 | 415.27 | 365.86 | 367.04 | 360.78 |
₹26405.00
↗ Bullish Moving Average
0
↘ Bearish Moving Average
16
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 75 | 75 | 75 | 75 | 75 | 75 |
| FII | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| DII | 9 | 9 | 8.9 | 9.1 | 9.1 | 9 |
| Public | 15.9 | 15.8 | 15.9 | 15.7 | 15.7 | 15.8 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 18.66 K | 24.57 K | 75.95% |
| Week | 8.89 K | 15.4 K | 57.74% |
| 1 Month | 6.39 K | 12.1 K | 52.83% |
| 6 Month | 5.11 K | 8.61 K | 59.35% |
Companies with no Debt
Benjamin Graham Value Screen
Relative Outperformance versus Industry over 1 Month
Expensive Performers (DVM)
Dividend yield greater than sector dividend yield
Relative Outperformance versus Industry over 1 Month
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Volume Shockers
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 25 Jul, 2025 | 475 | FINAL | 25 Jul, 2025 | Equity Share |
| 19 Jul, 2024 | 410 | FINAL | 19 Jul, 2024 | Equity Share |
| 21 Jul, 2023 | 145 | SPECIAL | 21 Jul, 2023 | Equity Share |
| 21 Jul, 2023 | 180 | FINAL | 21 Jul, 2023 | Equity Share |
| 02 Aug, 2022 | 130 | SPECIAL | Equity Share | |
| 02 Aug, 2022 | 145 | FINAL | Equity Share | |
| 19 Jul, 2021 | 155 | SPECIAL | Equity Share | |
| 19 Jul, 2021 | 120 | FINAL | Equity Share | |
| 28 Aug, 2020 | 143 | SPECIAL | Equity Share | |
| 28 Aug, 2020 | 107 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹673.60 | ₹967.85 | ₹1,596.80 | ₹1,999.70 | ₹1,725.10 | ₹1,035.50 |
| % Change | 2.64% | -0.43% | 0.08% | -0.30% | 1.71% | 4.31% |
| Revenue TTM (₹ Cr) | ₹1,996.59 | ₹2,169.86 | ₹8,850.08 | ₹13,914.08 | ₹6,112.77 | ₹6,721.63 |
| Net Profit TTM (₹ Cr) | ₹484.66 | ₹332.94 | ₹869.92 | ₹1,779.35 | ₹847.18 | ₹843.32 |
| PE TTM | 76.10 | 61.80 | 34.80 | 46.50 | 33.00 | 63.50 |
| 1 Year Return | 15.13 | 27.75 | 48.78 | -17.28 | 6.51 | 61.84 |
| ROCE | 26.88 | 12.51 | 20.80 | 13.27 | 11.43 | 11.82 |
Alkem Laboratories Ltd.
₹ 5264.00
-0.66%
Biocon Ltd.
₹ 369.25
+2.31%
Divi's Laboratories Ltd.
₹ 5912.50
-0.58%
Ajanta Pharma Ltd.
₹ 2828.90
+0.85%
Zydus Lifesciences Ltd.
₹ 873.60
+0.28%
Glenmark Pharmaceuticals Ltd.
₹ 2119.50
-0.57%
Aurobindo Pharma Ltd.
₹ 1344.40
+3.07%
Sun Pharmaceutical Industries Ltd.
₹ 1729.90
-1.55%
Ipca Laboratories Ltd.
₹ 1561.90
-2.45%
J B Chemicals & Pharmaceuticals Ltd.
₹ 2009.60
-2.65%
AstraZeneca Pharma India Ltd.
₹ 7867.00
+1.31%
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2335.60
+2.30%
Pfizer Ltd.
₹ 4833.30
+2.39%
Torrent Pharmaceuticals Ltd.
₹ 4153.40
-1.58%
Lupin Ltd.
₹ 2281.20
-1.41%
Dr. Reddy's Laboratories Ltd.
₹ 1228.00
-2.14%
Cipla Ltd.
₹ 1201.60
-1.85%
By signing up I certify terms, conditions & privacy policy